Short-term hypothyroidism after Levothyroxine-withdrawal in patients with differentiated thyroid cancer: clinical and quality of life consequences

被引:78
作者
Duntas, Leonidas H.
Biondi, Bernadette
机构
[1] Univ Athens, Endocrine Unit, Evgenidion Hosp, Athens 11528, Greece
[2] Univ Naples Federico II, Dept CLin & Mol Endocrinol & Oncol, Sch Med, Naples, Italy
关键词
D O I
10.1530/eje.1.02310
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Acute hypothyroidism induced by thyroid hormone withdrawal in patients with differentiated thyroid cancer during monitoring for remnant or metastatic disease, seriously affects multiple organs and systems, and especially in severe cases can impair quality of life. Indeed, it may induce untoward cardiovascular effects and can be hazardous in patients with underlying cardiovascular disease, particularly in the elderly. Moreover, acute hypothyroidism deranges the lipid profile and exacerbates neuropsychiatric illness. The introduction of recombinant human TSH (rhTSH) as a diagnostic and therapeutic tool in the care of patients with thyroid cancer has widened the scope of disease management. The use of rhTSH prevents derangement of various systems at approximately equivalent societal costs to that of withdrawal and promotes compliance while preserving the patient's normal daily functioning and productivity. Its reliability allied with its safety render this compound a valid alternative in the monitoring of patients with differentiated thyroid carcinoma as well as providing an alternative therapeutic procedure whenever LT4-withdrawal may be hazardous or in cases of patient non-compliance.
引用
收藏
页码:13 / 19
页数:7
相关论文
共 58 条
[1]  
[Anonymous], 1999, TIJDSCHR NUCL GENEES
[2]   Effect of thyroid hormones on cardiac function, geometry, and oxidative metabolism assessed noninvasively by positron emission tomography and magnetic resonance imaging [J].
Bengel, FM ;
Nekolla, SG ;
Ibrahim, T ;
Weniger, C ;
Ziegler, SI ;
Schwaiger, M .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (05) :1822-1827
[3]   Steroids, sex hormone-binding globulin, homocysteine, selected hormones and markers of lipid and carbohydrate metabolism in patients with severe hypothyroidism and their changes following thyroid hormone supplementation [J].
Bicíková, M ;
Hampl, R ;
Hill, M ;
Stanická, S ;
Tallová, J ;
Vondra, K .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2003, 41 (03) :284-292
[4]   Effects of subclinical thyroid dysfunction on the heart [J].
Biondi, B ;
Palmieri, EA ;
Lombardi, G ;
Fazio, S .
ANNALS OF INTERNAL MEDICINE, 2002, 137 (11) :904-914
[5]   Hypothyroidism as a risk factor for cardiovascular disease [J].
Biondi, B ;
Klein, I .
ENDOCRINE, 2004, 24 (01) :1-13
[6]   Cardiovascular safety of acute recombinant human thyrotropin administration to patients monitored for differentiated thyroid cancer [J].
Biondi, B ;
Palmieri, EA ;
Pagano, L ;
Klain, M ;
Scherillo, G ;
Salvatore, M ;
Fenzi, G ;
Lombardi, G ;
Fazio, S .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (01) :211-214
[7]   Subclinical hyperthyroidism: clinical features and treatment options [J].
Biondi, B ;
Palmieri, EA ;
Klain, M ;
Schlumberger, M ;
Filetti, S ;
Lombardi, G .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2005, 152 (01) :1-9
[8]  
BIONDI B, 2005, THYROID CARDIOVASCUL, P30
[9]   The effects of thyroid hormones on circulating markers of cell-mediated immune response, as studied in patients with differentiated thyroid carcinoma before and during thyroxine withdrawal [J].
Botella-Carretero, JI ;
Prados, A ;
Manzano, L ;
Montero, MT ;
Escribano, L ;
Sancho, J ;
Escobar-Morreale, HF .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2005, 153 (02) :223-230
[10]   Chronic thyrotropin-suppressive therapy with levothyroxine and short-term overt hypothyroidism after thyroxine withdrawal are associated with undesirable cardiovascular effects in patients with differentiated thyroid carcinoma [J].
Botella-Carretero, JI ;
Gómez-Bueno, M ;
Barrios, V ;
Caballero, C ;
García-Robles, R ;
Sancho, J ;
Escobar-Morreale, HF .
ENDOCRINE-RELATED CANCER, 2004, 11 (02) :345-356